Price to Public | Underwriting Discounts and Commissions(1) | Proceeds, Before Expenses, to Us | |||||||
Per Unit | $10.00 | $0.40 | $9.60 | ||||||
Total | $210,000,000 | $8,400,000 | $201,600,000 | ||||||
(1) | Including (a) $0.05 per unit sold in the offering, or $1,050,000 in the aggregate, payable upon the closing of this offering or up to $1,207,500 if the underwriters' over-allotment option is exercised; and (b) up to $0.35 per unit sold in the offering, or up to $7,350,000 in the aggregate (or up to $8,452,500 if the overallotment option is exercised in full) payable to the underwriters in this offering based on the percentage of funds remaining in the trust account after redemptions of public shares, for deferred underwriting commissions to be placed in a trust account located in the United States and released to the underwriters only upon the completion of an initial business combination. See “Underwriting” for a description of compensation and other items of value payable to the underwriters. |
• | “Additional Working Capital Loans” are to the loans that Sponsor HoldCo or an affiliate of the Sponsor HoldCo, or certain of the our officers and directors may, but are not obligated provide to us in order to finance transactions costs in connection with an intended initial business combination, up to $1,500,000 of which may be converted into Class A ordinary shares, at the option of Sponsor HoldCo; |
• | “amended and restated memorandum and articles of association” are to our amended and restated memorandum and articles of association to be in effect upon completion of this offering; |
• | “Clear Street” are to Clear Street LLC, the representative of the underwriters in this offering; |
• | “Companies Act” are to the Companies Act (As Revised) of the Cayman Islands as the same may be amended from time to time; |
• | “directors” are to our directors named in this prospectus; |
• | “Extension Period” are to extensions to the amount of time we will have to complete an initial business combination pursuant to an amendment to our amended and restated memorandum and articles of association as voted by our shareholders. There is no limit on the number of times our shareholders can vote to amend our amended and restated memorandum and articles of association to extend the amount of time we will have to complete an initial business combination and any such extension may be for any amount of time; |
• | “founder shares” are to our Class B ordinary shares initially purchased by Sponsor HoldCo, (i) 1,545,376 of which may be sold to non-Sponsor investors and certain of our directors at an aggregate purchase price of $3,800,032, (ii) 500,000 of which have been transferred to our independent directors and officers, for their services, and (iii) up to 200,000 of which may be transferred to certain of our advisors for services to us after the completion of this offering and prior to the closing of our our initial business combination, and our Class A ordinary shares that will be issued upon conversion thereof as provided herein; |
• | “GCAG” are to Global Client Advisory Group, a Cayman Islands exempted company controlled by Eric Swider; |
• | ‘‘Sarasota Global” are to Sarasota Global Enterprises, LLC, a Florida limited liability company controlled by Devin Nunes; |
• | “initial shareholders” are to Sponsor HoldCo, including any indirect holders of founder shares, through ownership of membership interests in Sponsor HoldCo, which interests represent an interest in the founder shares, and other holders of our founder shares prior to this offering, including, but not limited to, our independent directors and the non-Sponsor investors; |
• | “Insider Letter Agreement” are to the letter agreement to be entered into with Sponsor HoldCo and our officers and directors, the form of which will be filed as an exhibit to the registration statement of which this prospectus forms a part; |
• | “management” or our “management team” are to our directors and officers; |
• | “New RTAC” are to Renatus Tactical Acquisition Corp I from and after the business combination; |
• | “non-Sponsor investors” are to certain institutional investors (none of which are affiliated with any member of our management, Sponsor HoldCo Investors or any other investor) that have expressed an interest to purchase up to 1,545,376 founder shares from Sponsor HoldCo for an aggregate purchase price of 3,800,032 and to receive up to 772,688 private placement warrants from us upon the consummation of the private placement that will close simultaneously with the closing of this offering; |
• | “Non-Sponsor Investors Letter Agreement” are to the letter agreement to be entered into with each of the non-Sponsor investors, the form of which will be filed as an exhibit to the registration statement of which this prospectus forms a part. |
• | “ordinary shares” are to our Class A ordinary shares and our Class B ordinary shares; |
• | “Permitted Withdrawals” means amounts to be withdrawn from the trust account to pay our franchise and income taxes, provided that all permitted withdrawals can only be made (x) from interest earned (less up to $100,000 interest to pay dissolution expenses) and not from the principal held in the trust account and (y) only to the extent such interest is in amount sufficient to cover the permitted withdrawal amount; |
• | “private placement warrants” are to the warrants to be issued to Sponsor HoldCo and the non-Sponsor investors in a private placement to occur simultaneously with the closing of this offering, which private placement warrants are identical to the public warrants, subject to certain limited exceptions described in this prospectus, including, but not limited to, the number of shares of Class A ordinary shares underlying each warrant; |
• | “public shareholders” are to the holders of our public shares, including Sponsor HoldCo, Sponsor HoldCo Investors, the non-Sponsor investors, and our directors and officers to the extent such persons purchase public shares, provided their status as a “public shareholder” shall only exist with respect to such public shares; |
• | “public shares” are to our Class A ordinary shares sold as part of the units in this offering (whether they are purchased in this offering or thereafter in the open market); |
• | “public warrants” are to our warrants sold as part of the units in this offering (whether they are purchased in this offering or thereafter in the open market); |
• | “Sponsor HoldCo” are to International SPAC Management Group I LLC, a Cayman Islands limited liability company, formed by GCAG on July 3, 2024, which (i) currently holds all of the founder shares, (ii) upon consummation of the private placement that will close simultaneously with the closing of this offering, will hold 3,782,216 (or 3,821,591 if the underwriters’ option to purchase additional units is exercised in full) private placement warrants and (iii) simultaneously with the closing of this offering, will be issued a Working Capital Convertible Note in the principal amount of up to $442,500 (or up to $639,375 if the underwriters’ over-allotment option is exercised in full); |
• | “Sponsor HoldCo Investors” are to Global Client Advisory Group and Sarasota Global; |
• | “warrants” are, collectively, to the public warrants and the private placement warrants; |
• | “warrant agreement” are to our warrant agreement governing the warrants, the form of which will be filed as an exhibit to the registration statement of which this prospectus forms a part; |
• | “we,” “us,” “our,” “Company” or our “company” are to Renatus Tactical Acquisition Corp I, a Cayman Islands exempted company; |
• | “Working Capital Convertible Note” are to the convertible promissory note, the form of which is filed as an exhibit to the registration statement of which this prospectus forms a part, to be issued to Sponsor HoldCo simultaneously with the closing of this offering in the principal amount of up to $442,500 (or up to $639,375 if the underwriters’ over-allotment option is exercised in full), all of which may be converted into Class A, ordinary shares at the option of Sponsor HoldCo; and |
• | “$,” “US$” and “U.S. dollar” are to the United States dollar. |
(1) | Assumes no exercise of the over-allotment option and the full forfeiture of 914,514 shares that are subject to forfeiture by Sponsor HoldCo depending on the extent to which the underwriters’ over-allotment option is exercised. The Class B ordinary shares and the Class A ordinary shares issuable in connection with the conversion of the Class B ordinary shares may result in material dilution to our public shareholders due to the nominal price of $0.004 per share at which our sponsor purchased the Class B ordinary shares and/or the anti-dilution rights of our Class B ordinary shares that may result in an issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion. Our sponsor, directors and officers and their affiliates may receive additional compensation and/or may be issued additional securities in connection with an initial business combination, including securities that may result in material dilution to public shareholders. See “Risk Factors — The nominal purchase price paid by Sponsor HoldCo for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination.” on page 93, “— Risks Relating to our Securities — We may issue additional Class A ordinary shares or preference shares to complete our initial business combination or under an employee incentive plan after completion of our initial business combination. We may also issue Class A ordinary shares upon the conversion of the Class B ordinary shares at a ratio greater than one-to-one at the time of our initial business combination as a result of the anti-dilution provisions contained in our amended and restated memorandum and articles of association. Any such issuances would dilute the interest of our shareholders and likely present other risks.” on page 75, and “— Sponsor HoldCo paid an aggregate of $25,000, or approximately $0.004 per founder share and, accordingly, you will experience immediate and substantial dilution from the purchase of our Class A ordinary shares.” on page 82. |
(2) | The non-Sponsor investors and certain of our directors have expressed an interest to purchase up to 1,545,376 founder shares from Sponsor HoldCo for an aggregate purchase price of $3,800,032. |
(3) | As additional consideration to induce certain of our directors and the non-Sponsor investors to purchase founder shares from Sponsor HoldCo, Sponsor HoldCo will direct us to issue an aggregate of 772,688 of the 3,782,216 (or 3,821,591 if the underwriters’ option to purchase additional units is exercised in full) private placement warrants it is purchasing in the private placement from us to such non-Sponsor investors upon the consummation of the private placement that will close simultaneously with the closing of his offering, at no additional cost to such non-Sponsor investors. |
(4) | Upon the completion of this offering, we will issue Sponsor HoldCo a Working Capital Convertible Note in the principal amount of up to $442,500 (or up to $639,375 if the underwriters’ over-allotment option is exercised in full), which we may draw down in our sole discretion, from time to time, to finance transaction costs in connection with an intended initial business combination. Any principal amount outstanding under the Working Capital Convertible Note may be converted into Class A ordinary shares, at a conversion price per share equal to the lower of (i) $8.00 per share and (ii) the Note Conversion VWAP. See “Description of Securities — Ordinary Shares” on page 163. The conversion price of the of the Working Capital Convertible Note may be significantly less than the market price of our shares at the time such loan is converted. Any amount that is not converted into Class A ordinary shares will be repaid in cash on the maturity date. The maturity date of the Working Capital Convertible Note will be the earlier of (i) Lock-up Expiration Date and (ii) the date that our winding up becomes effective. |
(5) | After the completion of this offering, our board of directors may approve Additional Working Capital Loans for the purpose of funding working capital, which loans up to $1,500,000 of which may be converted into Class A ordinary shares, at a conversion price per share equal to the lower of (i) $8.00 per share and (ii) the Note Conversion VWAP. The conversion price of the working capital loans may be significantly less than the market price of our shares at the time such loans are converted. See “Description of Securities — Ordinary Shares” on page 163. |
(6) | Includes (i) 500,000 shares have been transferred to our independent directors and officers, prior to this offering and (ii) up to 200,000 of which may be transferred to certain of our advisors for services to us after the completion of this offering and prior to the closing of our our initial business combination. |
1. | Cryptocurrency and Blockchain. The cryptocurrency market has evolved into a significant global asset class, with a total market capitalization exceeding $1 trillion, driven by increasing institutional adoption and technological advancements. The global blockchain technology market size was estimated at USD 31.28 billion in 2024 and is projected to grow at a CAGR of 90.1% from 2025 to 2030. |
2. | Data Security. Traditionally data security has been nothing more than a buzz word. Major U.S. enterprises and government entities have struggled to find effective solutions to counter data breaches. As the world becomes more connected data has become much more ubiquitous, exposing much more than just sensitive data to these attacks. Americans are constantly bombarded with notices of data breach violations on an ever-increasing scale. This has led to a seismic shift in how society views data privacy as we have capitulated and ceded a once sacred right to privacy. |
3. | Dual Use Technologies. For many decades, the military industrial complex has focused on the profitable ecosystems based on bombs, missiles and physical weapons systems. As these systems have become much more sophisticated and a heightened degree of global geopolitical concerns there is a need to continue rapid advancements surrounding dual use technologies. |
• | Our public shareholders may not be afforded an opportunity to vote on our proposed business combination, which means we may complete our initial business combination even though a majority of our public shareholders do not support such a combination. |
• | If we seek shareholder approval of our initial business combination, our initial shareholders, directors and officers have agreed to vote in favor of such initial business combination, regardless of how our public shareholders vote. |
• | Your only opportunity to affect the investment decision regarding a potential business combination will be limited to the exercise of your right to redeem your shares from us for cash, unless we seek shareholder approval of such business combination. |
• | The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares and the amount of deferred underwriting commissions may not allow us to complete the most desirable business combination or optimize our capital structure, and may substantially dilute your investment in us. |
• | The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares could increase the probability that our initial business combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your shares. |
• | The requirement that we complete our initial business combination within the prescribed time frame or during any Extension Period may give potential target businesses leverage over us in negotiating a business combination and may limit the time we have in which to conduct due diligence on potential business combination targets, in particular as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms that would produce value for our shareholders. |
• | We may not be able to complete our initial business combination within the prescribed time frame or during any Extension Period, in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate, in which case our public shareholders may receive only $10.00 per share, or less than such amount in certain circumstances, and our warrants will expire worthless. |
• | Our search for an initial business combination, and any target business with which we may ultimately consummate an initial business combination, may be materially adversely affected by events that are outside of our control, such as increased geopolitical unrest, pandemic outbreaks (such as COVID-19), and volatility in the debt and equity markets. |
• | Changes in the market for directors and officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an initial business combination. |
• | If we seek shareholder approval of our initial business combination, Sponsor HoldCo, Sponsor HoldCo Investors, our initial shareholders, directors, officers, advisors or any of their affiliates may elect to purchase shares or public warrants from public shareholders, which may increase the likelihood of closing our initial business combination and reduce the public “float” of our securities. |
• | Because of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete our initial business combination within the required time period. If we have not completed our initial business combination within the required time period, our public shareholders may receive only their pro rata portion of the funds in the trust account that are available for distribution to public shareholders, and our warrants will expire worthless. |
• | As the number of SPACs evaluating targets increases, attractive targets may become scarcer and there may be more competition for attractive targets or such attractive targets may not be interested to consummate a business combination with a SPAC due to a negative public perception of mergers involving SPACs. This could increase the cost of our initial business combination and could even result in our inability to find a target or to consummate an initial business combination. |
• | If the funds not being held in the trust account are insufficient to allow us to operate for at least the 24 months following the closing of this offering (or up to 30 months from the closing of this offering if we extend the period of time to consummate a business combination by the full amount of time, as described in more detail in this prospectus) or during any Extension Period, we may be unable to complete our initial business combination. |
• | Because we are not limited to a particular industry or any specific target businesses with which to pursue our initial business combination, you will be unable to ascertain the merits or risks of any particular target business’s operations. |
• | We may seek business combination opportunities in industries or sectors that may be outside of our management’s areas of expertise. |
• | Although we have identified general criteria and guidelines that we believe are important in evaluating prospective target businesses, we may enter into our initial business combination with a target that does not meet such criteria and guidelines, and as a result, the target business with which we enter into our initial business combination may not have attributes entirely consistent with our general criteria and guidelines. |
• | We may seek acquisition opportunities with an early-stage company, a financially unstable business or an entity lacking an established record of revenue or earnings. |
• | We are not required to obtain an opinion from an independent investment banking firm or from a valuation or appraisal firm. Consequently, you may have no assurance from an independent source that the price we are paying for the business is fair to our shareholders from a financial point of view. |
• | Resources could be wasted in researching business combinations that are not completed, which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. |
• | If a shareholder fails to receive notice of our offer to redeem our public shares in connection with our initial business combination, or fails to comply with the procedures for submitting or tendering its shares, such shares may not be redeemed. |
• | You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. Therefore, to liquidate your investment, you may be forced to sell your public shares and/or warrants, potentially at a loss. |
• | Nasdaq may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions. |
• | Past performance by our directors, executive officers and their affiliates, including DWAC or its affiliates, including investments and transactions in which they have participated and businesses with which they have been associated, may not be indicative of future performance of an investment in us, and we may be unable to provide positive returns to shareholders. |
• | We may engage the underwriters or one of their affiliates to provide additional services to us after this offering, which may include acting as financial advisor in connection with an initial business combination or as placement agent in connection with a related financing transaction. The underwriters are entitled to receive deferred commissions that will be payable only upon completion of an initial business combination. These financial incentives may cause the underwriters to have potential conflicts of interest in rendering any such additional services to us after this offering, including, for example, in connection with the sourcing and consummation of an initial business combination. |
• | Because we are incorporated under the laws of the Cayman Islands, you may face difficulties in protecting your interests, and your ability to protect your rights through the U.S. federal courts may be limited. |
• | We have no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective. |
• | You will not be entitled to protections normally afforded to investors of many other blank check companies. |
• | one Class A ordinary share; and |
• | one-half of one redeemable public warrant. |
(1) | Assumes no exercise of the underwriters’ over-allotment option. |
(2) | Our initial shareholders currently hold 7,011,288 Class B ordinary shares through Sponsor HoldCo (which we refer to as “founder shares” as further described herein), up to 914,514 of which are subject to forfeiture by Sponsor HoldCo depending on the extent to which the underwriters’ over-allotment option is exercised. |
(3) | Founder shares are currently classified as Class B ordinary shares, which shares will convert into Class A ordinary shares on a one-for-one basis, subject to adjustment as described below adjacent to the caption “Founder shares conversion and anti-dilution rights.” |
(4) | Includes 21,000,000 public shares and 6,096,774 founder shares, which assumes no exercise of the underwriters’ over-allotment option and the forfeiture of 914,514 founder shares by Sponsor HoldCo. |
(5) | Includes 3,782,216 private placement warrants to be purchased in a private placement by Sponsor HoldCo, which assumes no exercise of the underwriters’ over-allotment option. |
(6) | Includes 10,500,000 public warrants, which assumes no exercise of the underwriters’ over-allotment option. |
(7) | Includes 772,688 private placement warrants to be issued as additional consideration for certain non-Sponsor investors’ purchase of founder shares from Sponsor HoldCo. |
• | 30 days after the completion of our initial business combination; and |
• | 12 months from the closing of this offering; |
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon not less than 30 days’ prior written notice of redemption to each warrant holder, which we refer to as the “30-day redemption period;” and |
• | if, and only if, the last reported sale price (the “closing price”) of our Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders has been at least $18.00 per share (as adjusted to the number of shares issuable upon exercise or the exercise price of a warrant as described elsewhere in this prospectus). |
• | prior to our initial business combination, only holders of the founder shares have the right to vote on the appointment of directors and holders of a majority of our founder shares may remove a member of the board of directors for any reason; |
• | 90% of the founder shares are subject to certain transfer restrictions, as described in more detail below; |
• | Sponsor HoldCo, our directors and officers and the non-Sponsor investors will enter into the Insider Letter Agreement and the Non-Sponsor Investor Letter Agreement with us, as applicable, pursuant to which they will agree to waive: (1) their redemption rights with respect to any founder shares and public shares held by them, as applicable, in connection with the completion of our initial business combination; (2) their redemption rights with respect to any founder shares and public shares held by them in |
• | the founder shares will automatically convert into our Class A ordinary shares at the time of our initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights, as described in more detail below; and |
• | the founder shares are entitled to registration rights as described under “Principal Shareholders — Registration Rights.” |
• | the net proceeds of this offering and the sale of the private placement warrants not held in the trust account, which will be approximately $922,500 (or |
• | the Working Capital Convertible Note in the principal amount of up to $442,500 (or up to $639,375 if the underwriters’ over-allotment option is exercised in full), which we may draw down in our sole discretion, from time to time and such loan will not have any claim on the proceeds held in the trust account unless such proceeds are released to us upon completion of our initial business combination; and |
• | any Additional Working Capital Loans or additional investments from Sponsor HoldCo, Sponsor HoldCo Investors, members of our management team or any of their affiliates or other third parties, although they are under no obligation to loan funds to, or otherwise invest in, us; and provided that any such loans will not have any claim on the proceeds held in the trust account unless such proceeds are released to us upon completion of our initial business combination. |
• | our registration statement/proxy statement filed for our business combination transaction would disclose the possibility that Sponsor HoldCo, Sponsor HoldCo Investors, and our directors, officers, advisors and their affiliates may purchase public shares or warrants from public shareholders outside the redemption process, along with the purpose of such purchases; |
• | if Sponsor HoldCo, Sponsor HoldCo Investors, or our directors, officers, advisors and their affiliates were to purchase public shares or warrants from public shareholders, they would do so at a price no higher than the price offered through our redemption process; |
• | our registration statement/proxy statement filed for our business combination transaction would include a representation that any of our securities purchased by Sponsor HoldCo, Sponsor HoldCo Investors, or our directors, officers, advisors and their affiliates would not be voted in favor of approving the business combination transaction; |
• | Sponsor HoldCo, Sponsor HoldCo Investors, and our directors, officers, advisors and their affiliates would not possess any redemption rights with respect to our securities or, if they do acquire and possess redemption rights, they would waive such rights; and |
• | we would disclose in a Form 8-K, before our security holder meeting to approve the business combination transaction, the following material items: |
○ | the amount of our securities purchased outside of the redemption offer by Sponsor HoldCo, Sponsor HoldCo Investors, our directors, officers, advisors and their affiliates, along with the purchase price; |
○ | the purpose of the purchases by Sponsor HoldCo, Sponsor HoldCo Investors, and our directors, officers, advisors and their affiliates; |
○ | the impact, if any, of the purchases by Sponsor HoldCo, Sponsor HoldCo Investors, and our directors, officers, advisors and their affiliates on the likelihood that the business combination transaction will be approved; |
○ | the identities of our security holders who sold to Sponsor HoldCo, Sponsor HoldCo |
○ | the number of our securities for which we have received redemption requests pursuant to our redemption offer. |
• | conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers; and |
• | file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies. |
• | conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules; and |
• | file proxy materials with the SEC. |
• | payment to Sponsor HoldCo or an affiliate thereof of a total of $25,000 per month for office space, utilities, secretarial and administrative support services; |
• | aggregate payment of up to approximately $6,000 per month in salary paid to Ian Rhodes for Chief Financial Officer services prior to the consummation of our initial business combination; |
• | payment of customary fees for financial advisory services; |
• | reimbursement for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination; |
• | repayment of the Working Capital Convertible Note made by Sponsor HoldCo to finance transaction costs in connection with an intended initial business combination, in the principal amount of up to $442,500 (or up to $639,375 if the underwriters’ over-allotment option is exercised in full), which we may draw down in our sole discretion, from time to time. Any principal amount outstanding under the Working Capital Convertible Note may be convertible into Class A ordinary shares of the post-business combination entity, at a conversion price per share equal to the lower of (i) $8.00 per share and (ii) the Note Conversion VWAP, at the option of Sponsor Holdco. Any Class A ordinary shares issued upon conversion of the Working Capital Convertible Note would be identical to the Class A ordinary shares that are sold as a part of the units of this offering; |
• | repayment of an aggregate of up to $300,000 in loans made to us by Sponsor HoldCo to cover offering-related and organizational expenses; |
• | repayment of loans which may be made by Sponsor HoldCo, Sponsor HoldCo Investors, any of their respective affiliates or certain of our directors and officers to finance transaction costs in connection with an intended initial business combination, the terms of which have not been |
• | payment to Ian Rhodes a total of approximately $6,000 per month for performing services as Chief Financial Officer of the Company. |
(1) | Expenses applied against gross proceeds include offering expenses of approximately $1,284,716 and underwriting discounts of $1,050,000 (excluding deferred underwriting commissions). See “Use of Proceeds.” |
(1) | Includes $3,782,216 we will receive from the sale of the private placement warrants. |
(2) | The “as adjusted” calculation equals actual shareholder’s equity (deficit) of $25,000 as of December 31, 2024 plus $922,500 in cash held outside the trust account less overallotment derivative liability of $314,396 as of December 31, 2024. |
(3) | The “as adjusted” calculation equals actual shareholder’s equity (deficit) of $25,000 as of December 31, 2024, plus $210,525,000 in cash held in trust from the proceeds of this offering and the sale of the private placement warrants, and plus $922,500 in cash held outside the trust account. |
(4) | The “as adjusted” calculation includes $7,350,000 of deferred underwriting commissions and $314,396 of over-allotment option liability. |
(5) | The “as adjusted” calculation equals the 21,000,000 Class A ordinary shares purchased in the public offering multiplied by the initial redemption value of $10.025 per share/unit. |
(6) | Excludes 25,000,000 Class A ordinary shares purchased in the public offering, which are subject to redemption in connection with our initial business combination. The “as adjusted” calculation equals the “as adjusted total assets,” less the “as adjusted” total liabilities, less the value of Class A ordinary shares that may be redeemed in connection with our initial business combination ($10.025 per share/unit). |
• | our ability to select an appropriate target business or businesses; |
• | our ability to complete our initial business combination, which is impacted by various factors; |
• | our expectations around the performance of a prospective target business or businesses or of markets or industries; |
• | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; |
• | our directors and officers allocating their time to other businesses and potentially having conflicts of interest with our business or in approving or consummating our initial business combination; |
• | our potential ability to obtain additional financing to complete our initial business combination; |
• | our pool of prospective target businesses; |
• | the ability of our directors and officers to generate a number of potential business combination opportunities; |
• | the potential liquidity and trading of our public securities; |
• | the past performance of our directors, executive officers and their affiliates may not be indicative of future performance of an investment in us; |
• | third parties may not want to engage with us to provide services due to the affiliation of our management team and our board of directors with TMTG and President Donald J. Trump; |
• | Certain members of our management team may have economic incentives that differ from those of public shareholders; |
• | the lack of a market for our securities; |
• | the use of proceeds not held in the trust account or available to us from interest income on the trust account balance; |
• | global geopolitical conditions resulting from the ongoing Russia-Ukraine conflict and the recent escalation of conflicts in the Middle East; |
• | the trust account not being subject to claims of third parties; or |
• | our financial performance following this offering. |
• | restrictions on the nature of our investments; and |
• | restrictions on the issuance of securities, each of which may make it difficult for us to complete our initial business combination. In addition, we may have imposed upon us burdensome requirements, including: |
• | registration as an investment company; |
• | adoption of a specific form of corporate structure; and |
• | reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations. |
• | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; |
• | our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding; |
• | our inability to pay dividends on our ordinary shares; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt. |
• | solely dependent upon the performance of a single business, property or asset; or |
• | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
• | a limited availability of market quotations for our securities; |
• | reduced liquidity for our securities; |
• | a determination that our Class A ordinary shares are a “penny stock” which will require brokers trading in our Class A ordinary shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; |
• | a limited amount of news and analyst coverage; and |
• | a decreased ability to issue additional securities or obtain additional financing in the future. |
• | the history and prospects of companies whose principal business is the acquisition of other companies; |
• | prior offerings of those companies; |
• | our prospects for acquiring an operating business at attractive values; |
• | a review of debt to equity ratios in leveraged transactions; |
• | our capital structure; |
• | an assessment of our management and their experience in identifying operating companies; |
• | general conditions of the securities markets at the time of this offering; and |
• | other factors as were deemed relevant. |
• | may significantly dilute the equity interest of investors in this offering, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion of the Class B ordinary shares; |
• | may subordinate the rights of holders of ordinary shares if preference shares are issued with rights senior to those afforded our ordinary shares; |
• | could cause a change of control if a substantial number of our ordinary shares is issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present directors and officers; |
• | may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; |
• | may adversely affect prevailing market prices for our units, ordinary shares and/or public warrants; and |
• | may not result in adjustment to the exercise price of our warrants. |
• | we issue additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at a Newly Issued Price of less than $9.20 per ordinary share; |
• | the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the completion of our initial business combination (net of redemptions); and |
• | the Market Value is below $9.20 per share, |
• | costs and difficulties inherent in managing cross-border business operations and complying with commercial and legal requirements of overseas markets; |
• | rules and regulations regarding currency redemption; |
• | complex corporate withholding taxes on individuals; |
• | laws governing the manner in which future business combinations may be effected; |
• | tariffs and trade barriers; |
• | regulations related to customs and import/export matters; |
• | longer payment cycles; |
• | tax consequences, such as tax law changes, including termination or reduction of tax and other incentives that the applicable government provides to domestic companies, and variations in tax laws as compared to the United States; |
• | currency fluctuations and exchange controls; |
• | rates of inflation; |
• | challenges in collecting accounts receivable; |
• | cultural and language differences; |
• | employment regulations; |
• | crime, strikes, riots, civil disturbances, terrorist attacks, natural disasters and wars; |
• | deterioration of political relations with the United States; |
• | obligatory military service by personnel; and |
• | government appropriation of assets. |
• | we have a board that includes a majority of “independent directors,” as defined under the rules of the Nasdaq; |
• | we have a compensation committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities; and |
• | a majority of the independent directors recommend director nominees for selection by the board of directors. |
(1) | Includes amounts payable to public shareholders who properly redeem their shares in connection with our successful completion of our initial business combination. |
(2) | A portion of the offering expenses have been paid from the proceeds of loans from Sponsor HoldCo. These loans will be repaid upon completion |
(3) | The underwriters have agreed to defer underwriting commissions of up to 3.5% of the gross proceeds of the units sold in the offering including pursuant to the over-allotment option. Accordingly, upon and concurrently with the completion of our initial business combination, up to $7,350,000 (or up to $8,452,500 if the underwriters’ over-allotment option is exercised in full) which constitutes the underwriters’ deferred commissions on the base offering and the overallotment option, if applicable, will be paid to the underwriters based on the percentage of funds remaining in the trust account after redemptions of public shares from the funds held in the trust account. The deferred commissions will be released to the underwriters only upon completion of an initial business combination. The remaining funds, less amounts released to the trustee to pay redeeming shareholders, will be released to us and can be used to pay all or a portion of the purchase price of the business or businesses with which our initial business combination occurs or for general corporate purposes, including payment of principal or interest on indebtedness incurred in connection with our initial business combination, to fund the purchases of other companies or for working capital. The underwriters will not be entitled to any interest accrued on the deferred underwriting commissions. |
(4) | Includes organizational and administrative expenses and may include amounts related to above-listed expenses in the event actual amounts exceed estimates. |
(5) | These expenses are estimates only. Our actual expenditures for some or all of these items may differ from the estimates set forth herein. For example, we may incur greater legal and accounting expenses than our current estimates in connection with negotiating and structuring a business combination based upon the level of complexity of such business combination. In the event we identify a business combination target in a specific industry subject to specific regulations, we may incur additional expenses associated with legal due diligence and the engagement of special legal counsel. In addition, our staffing needs may vary and as a result, we may engage a number of consultants to assist with legal and financial due diligence. We do not anticipate any change in our intended use of proceeds, other than fluctuations among the current categories of allocated expenses, which fluctuations, to the extent they exceed current estimates for any specific category of expenses, would not be available for our expenses. The amount in the table above does not include interest available to us from the trust account, which we may access to for Permitted Withdrawals. In addition, in order to finance transaction costs in connection with an intended initial business combination, either of Sponsor HoldCo, Sponsor HoldCo Investors, any of their respective affiliates or certain of our directors and officers may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. Otherwise, such loans may be repaid only out of funds held outside the trust account. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used to repay such loaned amounts. Up to $1,500,000 of such loans may be convertible into Class A ordinary shares, at a conversion price per share equal to the lower of (i) $8.00 per share and (ii) the Note Conversion VWAP, at the option of the lender. Any Class A ordinary shares issued upon conversion of such loans would be identical to the Class A ordinary shares that are sold as a part of the units of this offering. The terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than Sponsor HoldCo, Sponsor HoldCo Investors or an affiliate of either of Sponsor HoldCo or Sponsor HoldCo Investors, as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account. |
(1) | Expenses applied against gross proceeds include offering expenses of approximately $1,284,716 and underwriting discounts of $1,050,000 (excluding deferred underwriting commissions). See “Use of Proceeds.” |
(1) | Sponsor HoldCo has agreed to loan us up to $300,000 under an unsecured promissory note to be used for a portion of the expenses of this offering. As of March 14, 2025, there was $135,000 outstanding under such promissory note. |
(2) | Upon the consummation of our initial business combination, we will provide our shareholders (but not Sponsor HoldCo, our initial shareholders, officers, or directors) with the opportunity to redeem or sell their public shares, regardless of whether they abstain, vote for, or against, our initial business combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the trust account as of two business days prior to the consummation of the initial business combination, including interest (which interest shall be net of Permitted Withdrawals), subject to any limitations (including, but not limited to, cash requirements) created by the terms of the proposed business combination. |
(3) | Assumes the full forfeiture of 914,514 shares that are subject to forfeiture by Sponsor HoldCo depending on the extent to which the underwriters’ over-allotment option is exercised. The proceeds of the sale of such shares will not be deposited into the trust account, the shares will not be eligible for redemption from the trust account nor will they be eligible to vote upon the initial business combination. |
(4) | All of the 21,000,000 Class A ordinary shares sold as part of the units in the offering contain a redemption feature which allows for the redemption of such public shares in connection with our liquidation, if there is a shareholder vote or tender offer in connection with the business combination and in connection with certain amendments to our amended and restated memorandum and articles of association. In accordance with SEC guidance on redeemable equity instruments, which has been codified in ASC 480-10S99, redemption provisions not solely within the control of a company require ordinary shares subject to redemption to be classified outside of permanent equity. Given that the 21,000,000 Class A ordinary shares sold as part of the units in the offering will be issued with other freestanding instruments (i.e. public warrants), the initial carrying value of Class A ordinary shares classified as temporary equity will be the allocated proceeds determined in accordance with ASC 470-20. Our Class A ordinary shares are subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, we have the option to either (1) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable), or if later, to the earliest redemption date of the instrument, or (2) recognize changes in the redemption value immediately as they occur and adjust the carrying amounts of the instruments to equal the redemption value at the end of each reporting period. We have elected to recognize the changes immediately. The accretion or remeasurement will be treated as a deemed dividend (i.e. a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital). |
(5) | The “as adjusted” amount of ordinary shares, subject to redemption equals the “as adjusted” total assets of $211,472,500, less the “as adjusted” total liabilities of $7,664,396, less the “as adjusted” total shareholder’s deficit of $(6,716,896). The value of Class A ordinary shares that may be redeemed is equal to $10.025 per share (which is the assumed redemption price) multiplied by 21,000,000 Class A ordinary shares, which is the maximum number of Class A ordinary shares that may be redeemed for a $10.025 purchase price per share. The “as adjusted” amount is immediately accreted to redemption value and treated as a deemed dividend (i.e. a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital). |
(6) | Actual share amount is prior to any forfeiture of founder shares by the holders thereof (which depends on the extent to which the underwriters’ over-allotment option is exercised) and as adjusted share amount assumes no exercise of the underwriters’ over-allotment option. |
(7) | The “as adjusted” additional paid-in capital and accumulated deficit includes the immediate accretion of the carrying value of Class A ordinary shares subject to possible redemption to redemption value to reduce the additional paid-in capital to zero. |
(8) | Represents the value of 45-day over-allotment option from the date of this offering granted to the underwriters to purchase an aggregate of up to 3,150,000 additional units at the initial public offering price less the underwriting commissions. The over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and will be accounted for as a liability pursuant to ASC 480. |
• | may significantly dilute the equity interest of investors in this offering, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion of the Class B ordinary shares; |
• | may subordinate the rights of holders of ordinary shares if preference shares are issued with rights senior to those afforded our ordinary shares; |
• | could cause a change of control if a substantial number of our ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present directors and officers; |
• | may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; |
• | may adversely affect prevailing market prices for our units, ordinary shares and/or public warrants; and |
• | may not result in adjustment to the exercise price of our warrants. |
• | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; |
• | our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding; |
• | our inability to pay dividends on our ordinary shares; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt. |
• | staffing for financial, accounting and external reporting areas, including segregation of duties; |
• | reconciliation of accounts; |
• | proper recording of expenses and liabilities in the period to which they relate; |
• | evidence of internal review and approval of accounting transactions; |
• | documentation of processes, assumptions and conclusions underlying significant estimates; and |
• | documentation of accounting policies and procedures. |
• | subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial business combination; and |
• | cause us to depend on the marketing and sale of a single product or limited number of products or services. |
• | we issue Class A ordinary shares that will be equal to or in excess of 20% of the number of Class A ordinary shares then outstanding (other than in a public offering); |
• | any of our directors, officers or substantial security holders (as defined by Nasdaq rules) has a 5% or greater interest (or such persons collectively have a 10% or greater interest), directly or indirectly, in the target business or assets to be acquired or otherwise and the present or potential issuance of ordinary shares (or securities convertible into or exercisable for ordinary shares) could result in an increase in outstanding ordinary shares or voting power of 5% or more; or |
• | the issuance or potential issuance of ordinary shares will result in our undergoing a change of control. |
• | the timing of the transaction, including in the event we determine shareholder approval would require additional time and there is either not enough time to seek shareholder approval or doing so would place the company at a disadvantage in the transaction or result in other additional burdens on the company; |
• | the expected cost of holding a shareholder vote; |
• | the risk that the shareholders would fail to approve the proposed business combination; |
• | other time and budget constraints of the company; and |
• | additional legal complexities of a proposed business combination that would be time consuming and burdensome to present to shareholders. |
• | our registration statement/proxy statement filed for our business combination transaction would disclose the possibility that Sponsor HoldCo, Sponsor HoldCo Investors, and our directors, officers, advisors and their affiliates may purchase public shares or warrants from public shareholders outside the redemption process, along with the purpose of such purchases; |
• | if Sponsor HoldCo, Sponsor HoldCo Investors, or our directors, officers, advisors and their affiliates were to purchase public shares or warrants from public shareholders, they would do so at a price no higher than the price offered through our redemption process; |
• | our registration statement/proxy statement filed for our business combination transaction would include a representation that any of our securities purchased by Sponsor HoldCo, Sponsor HoldCo Investors, or our directors, officers, advisors and their affiliates would not be voted in favor of approving the business combination transaction; |
• | Sponsor HoldCo, Sponsor HoldCo Investors, and our directors, officers, advisors and their affiliates would not possess any redemption rights with respect to our securities or, if they do acquire and possess redemption rights, they would waive such rights; and |
• | we would disclose in a Form 8-K, before our security holder meeting to approve the business combination transaction, the following material items: |
○ | the amount of our securities purchased outside of the redemption offer by Sponsor HoldCo, Sponsor HoldCo Investors, and our directors, officers, advisors and their affiliates, along with the purchase price; |
○ | the purpose of the purchases by Sponsor HoldCo, Sponsor HoldCo Investors, and our directors, officers, advisors and their affiliates; |
○ | the impact, if any, of the purchases by Sponsor HoldCo, Sponsor HoldCo Investors, and our directors, officers, advisors and their affiliates on the likelihood that the business combination transaction will be approved; |
○ | the identities of our security holders who sold to Sponsor HoldCo, Sponsor HoldCo Investors, and our directors, officers, advisors and their affiliates (if not purchased on the open market) or the nature of our security holders (e.g., 5% security holders) who sold to Sponsor HoldCo, Sponsor HoldCo Investors, or our directors, officers, advisors and their affiliates; and |
○ | the number of our securities for which we have received redemption requests pursuant to our redemption offer. |
• | conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers; and |
• | file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies. |
• | conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules; and |
• | file proxy materials with the SEC. |
• | prior to the consummation of our initial business combination, we shall either (1) seek shareholder approval of our initial business combination at a general meeting called for such purpose at which public shareholders may seek to redeem their public shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction, or whether they were a public shareholder on the record date for the shareholder meeting held to approve the proposed transaction, into their pro rata share of the aggregate amount then on deposit in the trust account, calculated as of two business days prior to the completion of our initial business combination, including interest (which interest shall be net of Permitted Withdrawals), or (2) provide our public shareholders with the opportunity to tender their public shares to us by means of a tender offer (and thereby avoid the need for a shareholder vote) for an amount equal to their pro rata share of the aggregate amount then on deposit in the trust account, calculated as of two business days prior to the completion of our initial business combination, including interest (which interest shall be net of Permitted Withdrawals), in each case subject to the limitations described herein; |
• | our initial business combination must be approved by a majority of our board of directors and a majority of our independent directors; |
• | if we seek shareholder approval, we will complete our initial business combination only if we obtain the approval of an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the company; |
• | if our initial business combination is not consummated within 24 months from the closing of this offering (or up to 30 months from the closing of this offering if we extend the period of time to consummate a business combination by the full amount of time, as described in more detail in this prospectus) or during any Extension Period, then our existence will terminate and we will distribute all amounts in the trust account; and |
• | prior to our initial business combination, we may not issue additional ordinary shares that would entitle the holders thereof to (1) receive funds from the trust account or (2) vote as a class with our public shares on any initial business combination. |
Terms of Our Offering | Terms Under a Rule 419 Offering | |||||
whether we are requiring public shareholders to satisfy such delivery requirements. Accordingly, a public shareholder would have from the time we send out our tender offer materials until the close of the tender offer period, or up to two business days prior to the initially scheduled vote on the business combination if we distribute proxy materials, as applicable, to tender its shares if it wishes to seek to exercise its redemption rights. | ||||||
Name | Age | Title | ||||
Eric Swider | 52 | Chief Executive Officer and Director | ||||
Ian Rhodes | 53 | Chief Financial Officer | ||||
Alexander E. Cano | 51 | Chief Operating Officer | ||||
Devin G. Nunes | 51 | Director Nominee and Chairman of the Board | ||||
Jeffrey Smith | 51 | Director Nominee | ||||
Matan Fattal | 38 | Director Nominee | ||||
Randy Lambert | 54 | Director Nominee | ||||
• | assisting board oversight of (1) the integrity of our financial statements, (2) our compliance with legal and regulatory requirements, (3) our independent registered public accounting firm’s qualifications and independence, and (4) the performance of our internal audit function and independent registered public accounting firm; |
• | the appointment, compensation, retention, replacement, and oversight of the work of the independent registered public accounting firm and any other registered public accounting firm engaged by us; |
• | pre-approving all audit and non-audit services to be provided by the independent registered public accounting firm or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures; |
• | reviewing and discussing with the independent registered public accounting firm all relationships the independent registered public accounting firm has with us in order to evaluate their continued independence; |
• | setting clear hiring policies for employees or former employees of the independent registered public accounting firm; |
• | setting clear policies for audit partner rotation in compliance with applicable laws and regulations; |
• | obtaining and reviewing a report, at least annually, from the independent registered public accounting firm describing (1) the independent registered public accounting firm’s internal quality-control procedures and (2) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues; |
• | meeting to review and discuss our annual audited financial statements and quarterly financial statements with management and the independent registered public accounting firm, including reviewing our specific disclosures under “Management’s Discussion and Analysis of Financial Condition and Results of Operations;” |
• | reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and |
• | reviewing with management, the independent registered public accounting firm, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities. |
• | reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation; |
• | reviewing and making recommendations to our board of directors with respect to the compensation, and any incentive-compensation and equity-based plans that are subject to board approval of all of our other officers; |
• | reviewing our executive compensation policies and plans; |
• | implementing and administering our incentive compensation equity-based remuneration plans; |
• | assisting management in complying with our proxy statement and annual report disclosure requirements; |
• | approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees; |
• | producing a report on executive compensation to be included in our annual proxy statement; and |
• | reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. |
• | identifying, screening and reviewing individuals qualified to serve as directors, consistent with criteria approved by the board of directors, and recommending to the board of directors candidates for nomination for appointment at the annual general meeting or to fill vacancies on the board of directors; |
• | developing and recommending to the board of directors and overseeing implementation of our corporate governance guidelines; |
• | coordinating and overseeing the annual self-evaluation of the board of directors, its committees, individual directors and management in the governance of the company; and |
• | reviewing on a regular basis our overall corporate governance and recommending improvements as and when necessary. |
• | duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole; |
• | duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose; |
• | duty to not improperly fetter the exercise of future discretion; |
• | duty to exercise powers fairly as between different sections of shareholders; |
• | duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and |
• | duty to exercise independent judgment. |
• | None of our directors or officers is required to commit his or her full time to our affairs and, accordingly, may have conflicts of interest in allocating his or her time among various business activities. |
• | In the course of their other business activities, our directors and officers may become aware of investment and business opportunities that may be appropriate for presentation to us as well as the other entities with which they are affiliated. Our management may have conflicts of interest in determining to which entity a particular business opportunity should be presented. For a complete description of our management’s other affiliations, see “— Directors and Officers.” |
• | Sponsor HoldCo, our officers and directors and the non-Sponsor investors have agreed to waive their redemption rights with respect to any founder shares and public shares held by them in connection with the consummation of our initial business combination; provided that, pursuant to the Non-Sponsor Investor Letter Agreement, such waiver of redemption rights shall only be applicable to the founder shares held by the non-Sponsor investors, and not applicable to any public shares held by them. Additionally, Sponsor HoldCo, our officers and directors and the non-Sponsor investors have agreed to waive their redemption rights with respect to their founder shares if we fail to consummate our initial business combination within 24 months from the closing of this offering (or up to 30 months from the closing of this offering if we extend the period of time to consummate a business combination by the full amount of time, as described in more detail in this prospectus) or during any Extension Period. However, if Sponsor HoldCo, our officers and directors and the non-Sponsor investors (or any of our directors, officers or affiliates) acquire public shares, they will be entitled to liquidating distributions from the trust account with respect to such public shares if we fail to consummate our initial business combination within the prescribed time frame. If we do not complete our initial business combination within such applicable time period, the proceeds of the sale of the private placement warrants held in the trust account will be used to fund the redemption of our public shares, and the private placement warrants will expire worthless. With certain limited exceptions, the 90% of the founder shares will not be transferable, assignable or salable by our initial shareholders until the earlier of (x) six months after the date of the consummation of our initial business combination or (y) subsequent to our initial business combination (A) if the last reported sale price of our Class A ordinary shares equals or exceeds $12.50 per share (as adjusted for share sub-divisions, share dividends, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period, commencing at least 150 days after our initial business combination or (B) the date on which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. For the avoidance of doubt, 10% of the founder shares held by our Sponsor HoldCo, our officers and directors and the non-Sponsor investors shall not be subject to such transfer restrictions (such date on which the founder shares are no longer subject to restriction, the “Lock-up Expiration Date”). With certain limited exceptions, the private placement warrants and the Class A ordinary shares underlying such |
• | Our directors and officers may negotiate employment or consulting agreements with a target business in connection with a particular business combination. These agreements may provide for them to receive compensation following our initial business combination and as a result, may cause them to have conflicts of interest in determining whether to proceed with a particular business combination. |
• | Our directors and officers may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such directors and officers was included by a target business as a condition to any agreement with respect to our initial business combination. |
• | each person known by us to be the beneficial owner of more than 5% of our issued and outstanding ordinary shares; |
• | each of our directors and officers that beneficially owns ordinary shares; and |
• | all our directors and officers as a group. |
* | Less than one percent. |
(1) | Unless otherwise noted, the business address of each of the following entities or individuals is c/o Renatus Tactical Acquisition Corp I, 1825 Ponce de Leon Blvd, Suite 260, Coral Gables, Florida 33134. |
(2) | Interests shown consist solely of founder shares, classified as Class B ordinary shares. Such shares will convert into Class A ordinary shares on a one-for-one basis, subject to adjustment, as described in the section entitled “Description of Securities.” |
(3) | At the closing of this offering, Sponsor HoldCo is the record holder of 4,965,912 (or 4,051,398 if the underwriters do not elect to exercise their over-alottment option) founder shares. GCAG is the managing member of Sponsor HoldCo. Eric Swider is the managing member of GCAG. Devin Nunes indirectly owns a 50% economic interest in the founder shares held by Sponsor HoldCo through Sarasota Global, an entity which he controls. Mr. Swider makes all investment and voting decisions with respect to the securities held by Sponsor HoldCo, and may be deemed to beneficially own the founder shares held by Sponsor HoldCo. Includes 200,000 shares which may be transferred to certain of our advisors for services to us after the completion of this offering and prior to the closing of our our initial business combination. |
(4) | The non-Sponsor investors have expressed an interest to purchase up to 1,545,376 founder shares from Sponsor HoldCo for an aggregate purchase price of $3,800,032. |
(5) | Includes 500,000 shares which have been transferred to our independent directors and officers, prior to this offering. |
(6) | Does not include any Class A ordinary shares which may be issued upon conversion of the Working Capital Convertible Note or Additional Working Capital Loans. |
(7) | Includes 150,000 shares which Jeffrey Smith has expressed an interest to purchase from Sponsor HoldCo for an aggregate purchase price of $300,000. |
(8) | Includes 75,000 shares which Matan Fattal has expressed an interest to purchase from Sponsor HoldCo for an aggregate purchase price of $100,000. |
• | repayment of an aggregate of up to $300,000 in loans made to us by Sponsor HoldCo to cover offering-related and organizational expenses; |
• | repayment of the Working Capital Convertible Note made by Sponsor HoldCo to finance transaction costs in connection with an intended initial business combination, in the principal amount of up to $442,500 (or up to $639,375 if the underwriters’ over-allotment option is exercised in full), which we may draw down |
• | payment to our sponsor or an affiliate thereof of a total of $25,000 per month for office space, utilities, secretarial and administrative support services; |
• | aggregate payment of up to approximately $6,000 per month in salary paid to Ian Rhodes for Chief Financial Officer services prior to the consummation of our initial business combination; |
• | payment of customary fees for financial advisory services; |
• | reimbursement for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination; |
• | repayment of loans which may be made by Sponsor HoldCo, Sponsor HoldCo Investors, any of their respective affiliates or certain of our directors and officers to finance transaction costs in connection with an intended initial business combination, the terms of which have not been determined nor have any written agreements been executed with respect thereto. Up to $1,500,000 of such loans may be convertible into Class A ordinary shares of the post-business combination entity, at a conversion price per share equal to the lower of (i) $8.00 and (ii) the Note Conversion VWAP, at the option of the lender. The shares issuable upon conversion of such loans would be identical to the Class A ordinary shares that are sold as a part of the units of this offering; and |
• | payment of a total of $6,000 per month to Ian Rhodes for performing Chief Financial Officer services to us. |
• | 21,000,000 Class A ordinary shares underlying the units being offered in this offering; and |
• | 6,096,774 Class B ordinary shares held by our initial shareholders and their permitted transferees. |
• | the names and addresses of the members, a statement of the shares held by each member, and of the amount paid or agreed to be considered as paid, on the shares of each member and the voting rights of the shares of each member; |
• | whether voting rights are attached to the share in issue; |
• | the date on which the name of any person was entered on the register as a member; and |
• | the date on which any person ceased to be a member. |
• | in whole and not in part; |
• | at a price of $0.01 per public warrant; |
• | upon not less than 30 days’ prior written notice of redemption to each public warrant holder; and |
• | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “— Redemption procedures and cashless exercise — Anti-dilution Adjustments”) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to the public warrant holders. |
• | we are not proposing to act illegally or beyond the scope of our corporate authority and we have complied with the statutory provisions as to majority vote; |
• | the shareholders have been fairly represented at the meeting in question; |
• | the arrangement is such as a business-person would reasonably approve; and |
• | the arrangement is not one that would more properly be sanctioned under some other provision of the Companies Act or that would amount to a “fraud on the minority.” |
• | a company is acting, or proposing to act, illegally or beyond the scope of its authority; |
• | the act complained of, although not beyond the scope of the authority, could be effected if duly authorized by more than the number of votes that have actually been obtained; or |
• | those who control the company are perpetrating a “fraud on the minority.” |
• | an exempted company does not have to file an annual return of its shareholders with the Registrar of Companies; |
• | an exempted company’s register of members is not open to inspection; |
• | an exempted company does not have to hold an annual general meeting; |
• | an exempted company may issue shares with no par value; |
• | an exempted company may obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for 20 years in the first instance); |
• | an exempted company may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands; |
• | an exempted company may register as a limited duration company; and |
• | an exempted company may register as a segregated portfolio company. |
• | if we have not completed our initial business combination within 24 months from the closing of this offering (or up to 30 months from the closing of this offering if we extend the period of time to consummate a business combination by the full amount of time, as described in more detail in this prospectus) or during any Extension Period, we will: (1) cease all operations except for the purpose of winding up; (2) as promptly as reasonably possible but not more than 10 business days thereafter, redeem 100% of the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of Permitted Withdrawals), divided by the number of then issued and outstanding public shares, which redemption will completely extinguish public shareholder’s rights as shareholders (including the right to receive further liquidating distributions, if any); and (3) as promptly as reasonably possible |
• | prior to our initial business combination, we may not issue additional ordinary shares that would entitle the holders thereof to (1) receive funds from the trust account or (2) vote as a class with our public shares on any initial business combination; |
• | although we do not intend to enter into a business combination with a target business that is affiliated with Sponsor HoldCo, Sponsor HoldCo Investors or our directors or our officers, or the non-Sponsor investors, we are not prohibited from doing so. In the event we enter into such a transaction, we, or a committee of independent and disinterested directors, will obtain an opinion from an independent investment banking firm that is a member of FINRA or from a valuation or appraisal firm that such a business combination is fair to our shareholders from a financial point of view; |
• | if a shareholder vote on our initial business combination is not required by law and we do not decide to hold a shareholder vote for business or other reasons, we will offer to redeem our public shares pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, and will file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about our initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act; |
• | as long as our securities are listed on Nasdaq, our initial business combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the assets held in trust (excluding any deferred underwriters’ fees and Permitted Withdrawals on the interest income earned on the funds held in the trust account); |
• | if our shareholders approve an amendment to our amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of this offering (or up to 30 months from the closing of this offering if we extend the period of time to consummate a business combination by the full amount of time, as described in more detail in this prospectus) or (B) with respect to any other provision relating to shareholder’s rights or pre-initial business combination activity, we will provide our public shareholders with the opportunity to redeem all or a portion of their ordinary shares upon such approval at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (which interest shall be net of Permitted Withdrawals), divided by the number of then issued and outstanding public shares; and |
• | we will not effectuate our initial business combination solely with another blank check company or a similar company with nominal operations. |
• | where this is necessary for the performance of our rights and obligations under any purchase agreements; |
• | where this is necessary for compliance with a legal and regulatory obligation to which we are subject (such as compliance with anti-money laundering and FATCA/CRS requirements); and/or |
• | where this is necessary for the purposes of our legitimate interests and such interests are not overridden by your interests, fundamental rights or freedoms. |
• | 1% of the total number of Class A ordinary shares then issued and outstanding, which will equal 175,000 shares immediately after this offering (or 201,250 if the underwriters exercise their over-allotment option in full); or |
• | the average weekly reported trading volume of the Class A ordinary shares during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale. |
• | the issuer of the securities that was formerly a shell company has ceased to be a shell company; |
• | the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act; |
• | the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Current Reports on Form 8-K; and |
• | at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company. |
1. | that no law which is hereafter enacted in the Cayman Islands imposing any tax to be levied on profits, income, gains or appreciations shall apply to the Company or its operations; and |
2. | in addition, that no tax to be levied on profits, income, gains or appreciations or which is in the nature of estate duty or inheritance tax shall be payable: |
2.1 | on or in respect of the shares, debentures or other obligations of the Company; OR |
2.2 | by way of the withholding in whole or part, of any relevant payment as defined in Section 6(3) of the Tax Concessions Act (As Revised). |
3. | these concessions shall be for a period of 20 years from the date hereof. |
• | financial institutions or financial services entities; |
• | broker-dealers; |
• | taxpayers that are subject to the mark-to-market accounting rules; |
• | tax-exempt entities; |
• | governments or agencies or instrumentalities thereof; |
• | insurance companies; |
• | regulated investment companies; |
• | real estate investment trusts; |
• | controlled foreign corporations; |
• | PFICs; |
• | expatriates or former long-term residents of the United States; |
• | persons that actually or constructively own five percent or more of our shares by vote or value; |
• | Sponsor HoldCo, our founders, officers or directors or other holders of our Class B ordinary shares or private placement warrants; |
• | persons that acquired our securities pursuant to an exercise of employee share options, in connection with employee share incentive plans or otherwise as compensation or in connection with services; |
• | persons that hold our securities as part of a straddle, constructive sale, hedging, conversion or other integrated or similar transaction; |
• | partnerships or other pass-through entities for U.S. federal income tax purposes and any beneficial owners of such entities; or |
• | U.S. Holders (as defined below) whose functional currency is not the U.S. dollar. |
• | any gain recognized by the U.S. Holder on the sale or other disposition of its Class A ordinary shares or warrants; and |
• | any “excess distribution” made to the U.S. Holder (generally, any distributions to such U.S. Holder during a taxable year of the U.S. Holder that are greater than 125% of the average annual distributions received by such U.S. Holder in respect of the ordinary shares during the three preceding taxable years of such U.S. Holder or, if shorter, such U.S. Holder’s holding period for the Class A ordinary shares). |
• | the U.S. Holder’s gain or excess distribution will be allocated ratably over the U.S. Holder’s holding period for the Class A ordinary shares and warrants; |
• | the amount allocated to the U.S. Holder’s taxable year in which the U.S. Holder recognized the gain or received the excess distribution, or to the period in the U.S. Holder’s holding period before the first day of our first taxable year in which we are a PFIC, will be taxed as ordinary income; |
• | the amount allocated to other taxable years (or portions thereof) of the U.S. Holder and included in its holding period will be taxed at the highest tax rate in effect for that year and applicable to the U.S. Holder; and |
• | the interest charge generally applicable to underpayments of tax will be imposed in respect of the tax attributable to each such other taxable year of the U.S. Holder. |
Underwriters | Number of Units | ||
Clear Street LLC | 21,000,000 | ||
Total | 21,000,000 | ||
Payable by us | ||||||
No Exercise | Full Exercise | |||||
Underwriting discounts and commissions per unit(1) | $0.40 | $0.40 | ||||
Total(1) | $8,400,000 | $9,660,000 | ||||
(1) | Includes (a) $0.05 per unit sold in the offering, or $1,050,000 in the aggregate, is payable upon the closing of this offering (or up to $1,207,500 if the underwriters’ over-allotment option is exercised); and (b) up to $0.35 per unit sold in the offering, or up to $7,350,000 in the aggregate (or up to $8,452,500 if the overallotment option is exercised in full) is payable to the underwriters in this offering based on the percentage of funds remaining in the trust account after redemptions of public shares, for deferred underwriting commissions to be placed in a trust account located in the United States and released to the underwriters only upon the completion of an initial business combination. |
• | Stabilizing transactions permit bids to purchase securities so long as the stabilizing bids do not exceed a specified maximum and are engaged in for the purpose of preventing or retarding a decline in the market price of the securities while the offering is in progress. |
• | Over-allotment transactions involve sales by the underwriters of securities in excess of the number of securities the underwriters are obligated to purchase. This creates a syndicate short position which may be either a covered short position or a naked short position. In a covered short position, the number of securities over-allotted by the underwriters is not greater than the number of securities that they may purchase in the over-allotment option. In a naked short position, the number of securities involved is greater than the number of securities in the overallotment option. The underwriters may close out any short position by exercising their over-allotment option and/or purchasing securities in the open market. |
• | Syndicate covering transactions involve purchases of securities in the open market after the distribution has been completed in order to cover syndicate short positions. In determining the source of securities to close out the short position, the underwriters will consider, among other things, the price of securities available for purchase in the open market as compared with the price at which they may purchase securities through exercise of the over-allotment option. If the underwriters sell more securities than could be covered by exercise of the over-allotment option and, therefore, have a naked short position, the position can be closed out only by buying securities in the open market. A naked short position is more likely to be created if the underwriters are concerned that after pricing there could be downward pressure on the price of the securities in the open market that could adversely affect investors who purchase in the offering. |
• | Penalty bids permit the representative to reclaim a selling concession from a syndicate member when the securities originally sold by that syndicate member are purchased in stabilizing or syndicate covering transactions to cover syndicate short positions. |
• | to any legal entity which is a Qualified Investor as defined under the Prospectus Regulation; |
• | to fewer than 150 natural or legal persons (other than Qualified Investors as defined under the Prospectus Regulation), subject to obtaining the prior consent of the representative for any such offer; or |
• | in any other circumstances falling within Article 1(4) of the Prospectus Regulation; |
(a) | a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or |
(b) | a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor, securities or securities-based derivatives contracts (each term as defined in Section 2(1) of the SFA) of that corporation or the beneficiaries’ rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the shares pursuant to an offer made under Section 275 of the SFA except: |
(i) | to an institutional investor or to a relevant person, or to any person arising from an offer referred to in Section 275(1A) or Section 276(4)(i)(B) of the SFA; |
(ii) | where no consideration is or will be given for the transfer; |
(iii) | where the transfer is by operation of law; or |
(iv) | as specified in Section 276(7) of the SFA. |
December 31, 2024 | |||
ASSETS | |||
Current Assets: | |||
Prepaid expenses | $26,577 | ||
Total Current Assets | 26,577 | ||
Deferred offering costs | 597,798 | ||
Total Assets | $624,375 | ||
LIABILITIES AND SHAREHOLDER’S EQUITY | |||
Current Liabilities: | |||
Accrued offering costs | $599,375 | ||
Total Current Liabilities | 599,375 | ||
Commitments and contingencies (Note 6) | |||
Shareholder’s Equity: | |||
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | — | ||
Class A ordinary shares, $0.0001 par value, 200,000,000 shares authorized, none issued and outstanding | — | ||
Class B ordinary shares, $0.0001 par value, 20,000,000 shares authorized, 7,011,288 shares issued and outstanding(1)(2) | 701 | ||
Additional paid-in capital | 24,299 | ||
Retained earnings | — | ||
Total Shareholder’s Equity | 25,000 | ||
Total Liabilities and Shareholder’s Equity | $624,375 | ||
(1) | Includes an aggregate of up to 914,514 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 6). |
(2) | Shares and associated accounts have been retroactively restated to reflect the surrender of 3,740,591 Class B ordinary shares to the Company for no consideration on March 13, 2025 and the issuance of an additional 1,168,548 Class B ordinary shares to the Sponsor for no consideration on May 14, 2025. |
For the period From July 2, 2024 (inception) to December 31, 2024 | |||
Formation and operating expenses | $— | ||
TOTAL EXPENSES | — | ||
Net loss | — | ||
Weighted average shares outstanding basic and diluted(1)(2) | 5,192,308 | ||
Basic and diluted net loss per ordinary share | $(0.00) | ||
(1) | Excludes an aggregate of up to 914,514 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 6). |
(2) | Shares and associated accounts have been retroactively restated to reflect the surrender of 3,740,591 Class B ordinary shares to the Company for no consideration on March 13, 2025 and the issuance of an additional 1,168,548 Class B ordinary shares to the Sponsor for no consideration on May 14, 2025. |
Class B Ordinary Shares | |||||||||||||||
Shares | Amount | Additional Paid-In Capital | Accumulated Deficit | Shareholder’s Equity | |||||||||||
Balance, July 2, 2024 (inception) | — | $— | $— | $— | |||||||||||
Issuance of Class B ordinary shares to Sponsor(1)(2) | 7,011,288 | 701 | 24,299 | — | 25,000 | ||||||||||
Balance, December 31, 2024 | 7,011,288 | $701 | $24,299 | $— | $25,000 | ||||||||||
(1) | Includes an aggregate of up to 914,514 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 6). |
(2) | Shares and associated accounts have been retroactively restated to reflect the surrender of 3,740,591 Class B ordinary shares to the Company for no consideration on March 13, 2025 and the issuance of an additional 1,168,548 Class B ordinary shares to the Sponsor for no consideration on May 14, 2025. |
For the Period From July 2, 2024 (inception) to December 31, 2024 | |||
Cash Flows From Operating Activities: | |||
Net loss | $— | ||
Net Cash Provided By Operating Activities | — | ||
Net Cash Provided By Investing Activities | — | ||
Net Cash Provided By Financing Activities | — | ||
Net change in cash | — | ||
Cash at beginning of period | — | ||
Cash at end of period | $— | ||
Supplemental Schedule of Non-Cash Financing Activities: | |||
Issuance of Class B shares in exchange for a payment to a vendor | $25,000 | ||
Deferred offering costs included in accrued offering costs | $599,375 | ||
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
• | in whole and not in part; |
• | at a price of $0.01 per Public Warrant; |
• | upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period to each warrant holder; and |
• | if, and only if, the last reported sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, share dividends, reorganization, recapitalizations and the like) |